Industry
Medical - Devices
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
July 29, 2024 | 8:47 pm
Portfolio Pulse from Benzinga Newsdesk
July 29, 2024 | 8:18 pm
Portfolio Pulse from Benzinga Insights
June 17, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
June 05, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
June 05, 2024 | 10:52 am
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 7:46 pm
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 6:52 pm
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 5:19 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.